EDITORIAL-DETAILS (JPDM)
Xiaoqiang Xiang
Associate Professor
Fudan University
China
Biography
Dr. Xiang is currently an Associate Professor in the Department of Clinical Pharmacy, School of Pharmacy, Fudan University. He earned his B.S. in pharmaceutics from School of Pharmacy, Peking University and M.S. in Pharmacy from National University of Singapore. During 2005-2006, he worked as a research officer in Department of Clinical Pharmacology, National Cancer Centre Singapore where he conducted pharmacogenomic research of anticancer drugs and anticoagulant drugs. His research findings about the influence of SLCO1B1 polymorphism on the disposition of irinotecan in Asian cancer patients has been cited by the white paper of drug transporters. In 2007, he joined CombinatoRx Pte. Ltd. and worked as a DMPK scientist in the field of drug metabolism and drug-drug interactions. In 2008, Dr. Xiang moved to Finland to pursue his Ph.D degree under the supervision of Professor Pertti Neuvonen and Professor Mikko Niemi in the Department of Clinical Pharmacology, University of Helsinki. His Ph.D. research on the identification of the genetic factors contributing to the levels of endogenous bile acids and pharmacokinetics of therapeutic ursodeoxycholic acid won him Helsinki Biomedicum Funding award. Till now, he has published over 10 peer-reviewed papers in the field of clinical pharmacology.
Research Interest
Pharmacogenomic research of drug metabolizing enzymes and drug transporters, drug-drug interaction involving traditional Chinese medicine, and physiologically based pharmacokinetic modeling.
